# Immunogenicity and Safety of DTP/HB/Hib (Bio Farma)Compared to DTP/HB Given Simultaneously With Hib(Registered)Vaccine

> **NCT01986322** · PHASE2 · COMPLETED · sponsor: **PT Bio Farma** · enrollment: 220 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** DTP/HB/Hib vaccine
- **BIOLOGICAL:** DTP/HB and Hib vaccine

## Key facts

- **NCT ID:** NCT01986322
- **Lead sponsor:** PT Bio Farma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 220 (ACTUAL)
- **Last updated:** 2013-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01986322

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01986322, "Immunogenicity and Safety of DTP/HB/Hib (Bio Farma)Compared to DTP/HB Given Simultaneously With Hib(Registered)Vaccine". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01986322. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*